Barclays »

Ocuphire Pharma shares owned by Barclays

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0k 1.9k 1.05

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Opt Put Option (QQQ)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple Opt Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Tesla Opt Put Option (TSLA)
Ishares Tr Fund (HYG)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
Visa (V)
Alphabet Opt Put Option (GOOG)

View all positions for Barclays

Top funds holding Ocuphire Pharma

Geode Capital Management
Richmond Brothers
BlackRock
Citadel Advisors
Knoll Capital Management
Renaissance Technologies
Susquehanna International
Kestra Private Wealth Services
Empowered Funds
William Blair $ Company
Diametric Capital
Trust Co Of Toledo Na
Brian McDonald
Northern Trust
Virtu Financial

View all funds holding Ocuphire Pharma